Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities: Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

Author： Kimball Alexa B.  

Publisher： Adis International

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.12, Iss.1, 2011-02, pp. : 51-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Desloratadine in Adults with Chronic Idiopathic Urticaria: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

By Ortonne Jean-Paul  

American Journal of Clinical Dermatology, Vol. 8, Iss. 1, 2007-01 ,pp. : 37-42

Adis International

Access to resources Recommend Favorite

Effects of Alefacept on Health-Related Quality of Life in Patients with Psoriasis: Results from a Randomized, Placebo-Controlled Phase II Trial

By Ellis C.N.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 2, 2003-01 ,pp. : 131-139

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Calcipotriene 0.005% Foam for the Treatment of Plaque-Type Psoriasis: Results of Two Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Phase III Clinical Trials

By Feldman Steven R.  

American Journal of Clinical Dermatology, Vol. 13, Iss. 4, 2012-08 ,pp. : 261-271

Adis International

Access to resources Recommend Favorite

Effects of Vibration Therapy on Hormone Response and Stress in Severely Disabled Patients: A Double‐Blind Randomized Placebo‐Controlled Clinical Trial

By  

Rehabilitation Nursing, Vol. 40, Iss. 3, 2015-05 ,pp. : 166-178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous lysine clonixinate for the acute treatment of severe migraine attacks: a double-blind, randomized, placebo-controlled study

By Krymchantowski A.V.   Silva M.T.T.  

Current Therapeutic Research, Vol. 64, Iss. 8, 2003-09 ,pp. : 505-513

Elsevier

Access to resources Recommend Favorite